MedTrace Logo

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain

NCT01302275 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2014-05-05

No results posted yet for this study

Summary

The purpose of this trial is to determine if the effect of oxcarbazepine on chronic peripheral nerve pain depends on the supposed mechanism of the pain, ie. if oxcarbazepine mainly relieve pain in patients with irritable nerves.

Conditions

  • Polyneuropathy
  • Peripheral Nerve Injury
  • Postherpetic Neuralgia

Interventions

DRUG

Oxcarbazepine

Oxcarbazepine capsules 300 mg is gradually increased from 300 mg/day to 2400 mg/day Placebo capsules increase from 1/day to 8/day

Sponsors & Collaborators

  • Danish Pain Research Center

    collaborator OTHER

  • Innovative Medicines Initiative

    collaborator OTHER

  • Søren H. Sindrup

    lead OTHER

Principal Investigators

  • Søren H Sindrup, MD · Department of Neurology, Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302275 on ClinicalTrials.gov